Literature DB >> 18970924

Stem cells as a potential future treatment of pediatric intestinal disorders.

Troy A Markel1, Paul R Crisostomo, Tim Lahm, Nathan M Novotny, Frederick J Rescorla, Joseph Tector, Daniel R Meldrum.   

Abstract

All surgical disciplines encounter planned and unplanned ischemic events that may ultimately lead to cellular dysfunction and death. Stem cell therapy has shown promise for the treatment of a variety of ischemic and inflammatory disorders where tissue damage has occurred. As stem cells have proven beneficial in many disease processes, important opportunities in the future treatment of gastrointestinal disorders may exist. Therefore, this article will serve to review the different types of stem cells that may be applicable to the treatment of gastrointestinal disorders, review the mechanisms suggesting that stem cells may work for these conditions, discuss current practices for harvesting and purifying stem cells, and provide a concise summary of a few of the pediatric intestinal disorders that could be treated with cellular therapy.

Entities:  

Mesh:

Year:  2008        PMID: 18970924      PMCID: PMC2584666          DOI: 10.1016/j.jpedsurg.2008.06.019

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  163 in total

1.  Hepatocytes from non-hepatic adult stem cells.

Authors:  M R Alison; R Poulsom; R Jeffery; A P Dhillon; A Quaglia; J Jacob; M Novelli; G Prentice; J Williamson; N A Wright
Journal:  Nature       Date:  2000-07-20       Impact factor: 49.962

2.  Bone marrow contributes to renal parenchymal turnover and regeneration.

Authors:  R Poulsom; S J Forbes; K Hodivala-Dilke; E Ryan; S Wyles; S Navaratnarasah; R Jeffery; T Hunt; M Alison; T Cook; C Pusey; N A Wright
Journal:  J Pathol       Date:  2001-09       Impact factor: 7.996

3.  Keratinocyte growth factor-2 (FGF-10) promotes healing of experimental small intestinal ulceration in rats.

Authors:  D S Han; F Li; L Holt; K Connolly; M Hubert; R Miceli; Z Okoye; G Santiago; K Windle; E Wong; R B Sartor
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2000-11       Impact factor: 4.052

4.  Insulin-like growth factor I and insulin-like growth factor binding protein 5 in Crohn's disease.

Authors:  E M Zimmermann; L Li; Y T Hou; N K Mohapatra; J B Pucilowska
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-05       Impact factor: 4.052

5.  Protective effect of ischemic preconditioning on cold preservation and reperfusion injury associated with rat intestinal transplantation.

Authors:  A Sola; J De Oca; R González; N Prats; J Roselló-Catafau; E Gelpí; E Jaurrieta; G Hotter
Journal:  Ann Surg       Date:  2001-07       Impact factor: 12.969

6.  Nonmyeloablative stem cell therapy enhances microcirculation and tissue regeneration in murine inflammatory bowel disease.

Authors:  Philipe N Khalil; Véronique Weiler; Peter J Nelson; Maurice N Khalil; Sabine Moosmann; Wolf E Mutschler; Matthias Siebeck; Ralf Huss
Journal:  Gastroenterology       Date:  2006-12-19       Impact factor: 22.682

7.  Immune depression in polymicrobial sepsis: the role of necrotic (injured) tissue and endotoxin.

Authors:  A Ayala; G Y Song; C S Chung; K M Redmond; I H Chaudry
Journal:  Crit Care Med       Date:  2000-08       Impact factor: 7.598

8.  Estradiol administration improves splanchnic perfusion following trauma-hemorrhage and sepsis.

Authors:  Joachim F Kuebler; Doraid Jarrar; Balazs Toth; Kirby I Bland; Loring Rue; Ping Wang; Irshad H Chaudry
Journal:  Arch Surg       Date:  2002-01

9.  Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives.

Authors:  Valérie Planat-Benard; Jean-Sébastien Silvestre; Béatrice Cousin; Mireille André; Maryse Nibbelink; Radia Tamarat; Michel Clergue; Carole Manneville; Corinne Saillan-Barreau; Micheline Duriez; Alain Tedgui; Bernard Levy; Luc Pénicaud; Louis Casteilla
Journal:  Circulation       Date:  2004-01-20       Impact factor: 29.690

10.  Expression of Musashi-1 in human normal colon crypt cells: a possible stem cell marker of human colon epithelium.

Authors:  Satoshi Nishimura; Naoki Wakabayashi; Kazuyuki Toyoda; Kei Kashima; Shoji Mitsufuji
Journal:  Dig Dis Sci       Date:  2003-08       Impact factor: 3.199

View more
  24 in total

1.  Heparin-binding epidermal growth factor-like growth factor restores Wnt/β-catenin signaling in intestinal stem cells exposed to ischemia/reperfusion injury.

Authors:  Chun-Liang Chen; Jixin Yang; Iyore O A James; Hong-Yi Zhang; Gail E Besner
Journal:  Surgery       Date:  2014-02-06       Impact factor: 3.982

Review 2.  ES, iPS, MSC, and AFS cells. Stem cells exploitation for Pediatric Surgery: current research and perspective.

Authors:  Michela Pozzobon; Marco Ghionzoli; Paolo De Coppi
Journal:  Pediatr Surg Int       Date:  2009-09-01       Impact factor: 1.827

3.  Intestinal stem cells and stem cell-based therapy for intestinal diseases.

Authors:  Mahmoud Shaaban Mohamed; Yun Chen; Chao-Ling Yao
Journal:  Cytotechnology       Date:  2014-07-01       Impact factor: 2.058

4.  Characterization of discrete equine intestinal epithelial cell lineages.

Authors:  Liara M Gonzalez; Leslie A Kinnin; Anthony T Blikslager
Journal:  Am J Vet Res       Date:  2015-04       Impact factor: 1.156

5.  Preservation of reserve intestinal epithelial stem cells following severe ischemic injury.

Authors:  Liara M Gonzalez; Amy Stieler Stewart; John Freund; Cecilia Renee Kucera; Christopher M Dekaney; Scott T Magness; Anthony T Blikslager
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-02-04       Impact factor: 4.052

Review 6.  Equine Intestinal Mucosal Pathobiology.

Authors:  Anthony Blikslager; Liara Gonzalez
Journal:  Annu Rev Anim Biosci       Date:  2017-11-16       Impact factor: 8.923

Review 7.  Stem cell therapy in necrotizing enterocolitis: Current state and future directions.

Authors:  Natalie A Drucker; Christopher J McCulloh; Bo Li; Agostino Pierro; Gail E Besner; Troy A Markel
Journal:  Semin Pediatr Surg       Date:  2017-11-07       Impact factor: 2.754

Review 8.  Mesenchymal stromal cell therapy for the treatment of intestinal ischemia: Defining the optimal cell isolate for maximum therapeutic benefit.

Authors:  Dominique L Doster; Amanda R Jensen; Sina Khaneki; Troy A Markel
Journal:  Cytotherapy       Date:  2016-10-10       Impact factor: 5.414

9.  Stem cells and necrotizing enterocolitis: A direct comparison of the efficacy of multiple types of stem cells.

Authors:  Christopher J McCulloh; Jacob K Olson; Yu Zhou; Yijie Wang; Gail E Besner
Journal:  J Pediatr Surg       Date:  2017-03-18       Impact factor: 2.545

10.  Effects of mesenchymal stem cells and VEGF on liver regeneration following major resection.

Authors:  Gokhan Adas; Bora Koc; Mine Adas; Gokhan Duruksu; Cansu Subasi; Ozgur Kemik; Ahu Kemik; Damlanur Sakiz; Mustafa Kalayci; Sevim Purisa; Seda Unal; Erdal Karaoz
Journal:  Langenbecks Arch Surg       Date:  2016-04-19       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.